Compare KWR & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KWR | GRDN |
|---|---|---|
| Founded | 1918 | 2004 |
| Country | United States | United States |
| Employees | N/A | 3600 |
| Industry | Major Chemicals | Retail-Drug Stores and Proprietary Stores |
| Sector | Industrials | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 1994 | N/A |
| Metric | KWR | GRDN |
|---|---|---|
| Price | $159.43 | $41.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $167.00 | $40.60 |
| AVG Volume (30 Days) | 157.7K | ★ 476.8K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.13 | N/A |
| Revenue | ★ $1,888,634,000.00 | N/A |
| Revenue This Year | $5.16 | N/A |
| Revenue Next Year | $3.63 | $7.63 |
| P/E Ratio | $142.62 | ★ $117.77 |
| Revenue Growth | ★ 2.66 | N/A |
| 52 Week Low | $111.42 | $19.30 |
| 52 Week High | $183.01 | $44.00 |
| Indicator | KWR | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 65.72 | 54.51 |
| Support Level | $128.25 | $27.73 |
| Resistance Level | $162.10 | $44.00 |
| Average True Range (ATR) | 5.07 | 2.03 |
| MACD | 1.00 | -0.09 |
| Stochastic Oscillator | 85.81 | 60.00 |
Quaker Houghton manufactures and sells a variety of industrial process fluids. The company's product portfolio includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. The company's geographic segments include the Americas, EMEA, and Asia/Pacific. The majority of the company's revenue is earned from the Americas.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.